vs
Healthpeak Properties（DOC）与Privia Health Group, Inc.（PRVA）财务数据对比。点击上方公司名可切换其他公司
Healthpeak Properties的季度营收约是Privia Health Group, Inc.的1.3倍（$719.4M vs $541.2M），Healthpeak Properties净利率更高（73.2% vs 1.7%，领先71.5%），Privia Health Group, Inc.同比增速更快（17.4% vs 3.1%），过去两年Privia Health Group, Inc.的营收复合增速更高（14.2% vs 8.9%）
Healthpeak Properties是美国医疗地产领域的房地产投资信托基金，核心投资范畴覆盖老年住宅、生命科学相关物业及医疗办公楼三类资产。公司2007年于马里兰州组建，总部设在科罗拉多州丹佛市，在尔湾、纳什维尔、旧金山均设有办事处，截至2019年12月31日共持有617处物业的权益。
Privia Health Group, Inc.是总部位于美国的医疗科技与服务企业，为独立诊所、医疗系统和医疗支付方提供价值导向型医疗解决方案，涵盖人群健康管理、患者互动平台、护理协调支持及行政流程优化工具，助力提升诊疗效果、降低医疗参与方运营成本。
DOC vs PRVA — 直观对比
营收规模更大
DOC
是对方的1.3倍
$541.2M
营收增速更快
PRVA
高出14.3%
3.1%
净利率更高
DOC
高出71.5%
1.7%
两年增速更快
PRVA
近两年复合增速
8.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $719.4M | $541.2M |
| 净利润 | $114.0M | $9.2M |
| 毛利率 | — | — |
| 营业利润率 | 17.4% | 2.1% |
| 净利率 | 73.2% | 1.7% |
| 营收同比 | 3.1% | 17.4% |
| 净利润同比 | 2406.4% | 108.0% |
| 每股收益（稀释后） | $0.16 | $0.08 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DOCPRVA
| Q4 25 | $719.4M | $541.2M | ||
| Q3 25 | $705.9M | $580.4M | ||
| Q2 25 | $694.3M | $521.2M | ||
| Q1 25 | $702.9M | $480.1M | ||
| Q4 24 | $698.0M | $460.9M | ||
| Q3 24 | $700.4M | $437.9M | ||
| Q2 24 | $695.5M | $422.3M | ||
| Q1 24 | $606.6M | $415.2M |
净利润DOCPRVA
| Q4 25 | $114.0M | $9.2M | ||
| Q3 25 | $-117.1M | $6.9M | ||
| Q2 25 | $31.7M | $2.7M | ||
| Q1 25 | $42.8M | $4.2M | ||
| Q4 24 | $4.5M | $4.4M | ||
| Q3 24 | $85.9M | $3.5M | ||
| Q2 24 | $146.0M | $3.5M | ||
| Q1 24 | $6.7M | $3.0M |
毛利率DOCPRVA
| Q4 25 | — | — | ||
| Q3 25 | 58.6% | — | ||
| Q2 25 | 60.2% | — | ||
| Q1 25 | 61.1% | — | ||
| Q4 24 | 60.3% | — | ||
| Q3 24 | 60.0% | — | ||
| Q2 24 | 60.6% | — | ||
| Q1 24 | 59.8% | — |
营业利润率DOCPRVA
| Q4 25 | 17.4% | 2.1% | ||
| Q3 25 | 9.2% | 2.5% | ||
| Q2 25 | 5.7% | 0.6% | ||
| Q1 25 | 7.7% | 1.1% | ||
| Q4 24 | -2.2% | 1.1% | ||
| Q3 24 | 14.1% | 1.3% | ||
| Q2 24 | 22.3% | 1.2% | ||
| Q1 24 | 3.7% | 0.2% |
净利率DOCPRVA
| Q4 25 | 73.2% | 1.7% | ||
| Q3 25 | -16.6% | 1.2% | ||
| Q2 25 | 4.6% | 0.5% | ||
| Q1 25 | 6.1% | 0.9% | ||
| Q4 24 | 0.7% | 1.0% | ||
| Q3 24 | 12.3% | 0.8% | ||
| Q2 24 | 21.0% | 0.8% | ||
| Q1 24 | 1.1% | 0.7% |
每股收益（稀释后）DOCPRVA
| Q4 25 | $0.16 | $0.08 | ||
| Q3 25 | $-0.17 | $0.05 | ||
| Q2 25 | $0.05 | $0.02 | ||
| Q1 25 | $0.06 | $0.03 | ||
| Q4 24 | $0.02 | $0.03 | ||
| Q3 24 | $0.12 | $0.03 | ||
| Q2 24 | $0.21 | $0.03 | ||
| Q1 24 | $0.01 | $0.02 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $467.5M | $479.7M |
| 总债务越低越好 | $9.8B | — |
| 股东权益账面价值 | $7.5B | $737.2M |
| 总资产 | $20.3B | $1.4B |
| 负债/权益比越低杠杆越低 | 1.31× | — |
8季度趋势，按日历期对齐
现金及短期投资DOCPRVA
| Q4 25 | $467.5M | $479.7M | ||
| Q3 25 | $91.0M | $441.4M | ||
| Q2 25 | $89.4M | $390.1M | ||
| Q1 25 | $70.6M | $469.3M | ||
| Q4 24 | $119.8M | $491.1M | ||
| Q3 24 | $180.4M | $422.0M | ||
| Q2 24 | $106.9M | $387.4M | ||
| Q1 24 | $101.8M | $351.1M |
总债务DOCPRVA
| Q4 25 | $9.8B | — | ||
| Q3 25 | $9.1B | — | ||
| Q2 25 | $9.0B | — | ||
| Q1 25 | $8.9B | — | ||
| Q4 24 | $8.7B | — | ||
| Q3 24 | $8.6B | — | ||
| Q2 24 | $8.6B | — | ||
| Q1 24 | $8.8B | — |
股东权益DOCPRVA
| Q4 25 | $7.5B | $737.2M | ||
| Q3 25 | $7.6B | $709.1M | ||
| Q2 25 | $7.9B | $682.9M | ||
| Q1 25 | $8.2B | $659.4M | ||
| Q4 24 | $8.4B | $635.2M | ||
| Q3 24 | $8.6B | $614.9M | ||
| Q2 24 | $8.8B | $595.4M | ||
| Q1 24 | $8.9B | $576.8M |
总资产DOCPRVA
| Q4 25 | $20.3B | $1.4B | ||
| Q3 25 | $19.6B | $1.4B | ||
| Q2 25 | $19.8B | $1.3B | ||
| Q1 25 | $19.8B | $1.2B | ||
| Q4 24 | $19.9B | $1.1B | ||
| Q3 24 | $20.0B | $1.1B | ||
| Q2 24 | $20.2B | $1.1B | ||
| Q1 24 | $20.5B | $1.0B |
负债/权益比DOCPRVA
| Q4 25 | 1.31× | — | ||
| Q3 25 | 1.20× | — | ||
| Q2 25 | 1.14× | — | ||
| Q1 25 | 1.08× | — | ||
| Q4 24 | 1.04× | — | ||
| Q3 24 | 1.00× | — | ||
| Q2 24 | 0.98× | — | ||
| Q1 24 | 0.99× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $1.3B | $127.5M |
| 自由现金流经营现金流 - 资本支出 | $357.0M | — |
| 自由现金流率自由现金流/营收 | 49.6% | — |
| 资本支出强度资本支出/营收 | 124.4% | — |
| 现金转化率经营现金流/净利润 | 10.99× | 13.93× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流DOCPRVA
| Q4 25 | $1.3B | $127.5M | ||
| Q3 25 | $315.0M | $52.0M | ||
| Q2 25 | $363.5M | $8.0M | ||
| Q1 25 | $279.4M | $-24.1M | ||
| Q4 24 | $1.1B | $74.8M | ||
| Q3 24 | $318.2M | $33.2M | ||
| Q2 24 | $316.2M | $34.5M | ||
| Q1 24 | $152.6M | $-33.1M |
自由现金流DOCPRVA
| Q4 25 | $357.0M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $333.7M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
自由现金流率DOCPRVA
| Q4 25 | 49.6% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 47.8% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资本支出强度DOCPRVA
| Q4 25 | 124.4% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 105.6% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金转化率DOCPRVA
| Q4 25 | 10.99× | 13.93× | ||
| Q3 25 | — | 7.58× | ||
| Q2 25 | 11.48× | 2.97× | ||
| Q1 25 | 6.52× | -5.70× | ||
| Q4 24 | 235.43× | 17.00× | ||
| Q3 24 | 3.71× | 9.38× | ||
| Q2 24 | 2.17× | 9.94× | ||
| Q1 24 | 22.85× | -11.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DOC
暂无分部数据
PRVA
| FFS Patient Care | $364.4M | 67% |
| Capitated Revenue | $71.4M | 13% |
| Shared Savings | $46.9M | 9% |
| FFS Administrative Services | $36.0M | 7% |
| Care Management Fee PMPM | $20.0M | 4% |
| Other Revenue | $2.5M | 0% |
